OM:SOBI
OM:SOBIBiotechs

How Sobi’s Clinical Trial Results and FDA Approvals at ACR 2025 Will Impact (OM:SOBI) Investors

In October 2025, Swedish Orphan Biovitrum (Sobi) presented 15 scientific abstracts, including late-stage clinical trial results for Nanoencapsulated Sirolimus plus Pegadricase, Vonjo, and Gamifant, at the American College of Rheumatology (ACR) Convergence meeting in Chicago, with updates on both new safety data and recent US FDA approvals. The company highlighted its strengthened leadership in rare and underserved inflammatory conditions, with the presentation of advanced clinical data and...
OM:ELUX B
OM:ELUX BConsumer Durables

A Look at Electrolux (OM:ELUX B) Valuation Following Its Return to Profitability and Strategic Restructuring

AB Electrolux (OM:ELUX B) returned to profitability in the third quarter of 2025, reporting improved operating income and a net profit compared to a loss last year. The company also introduced a new organizational structure and adjusted its business outlook. See our latest analysis for AB Electrolux. Despite a remarkable turnaround in profitability and the recent organizational shake-up, AB Electrolux’s share price remains well below where it started the year. While the stock saw an...
OM:MYCR
OM:MYCRElectronic

Does Mycronic’s (OM:MYCR) Sales Guidance Signal Steadfast Management or Mask Underlying Volatility?

Mycronic AB reported third-quarter 2025 earnings with sales of SEK 1,709 million and net income of SEK 217 million, both lower than the previous year, but posted year-to-date sales of SEK 5.92 billion and net income of SEK 1.28 billion, both above prior-year levels. Despite the softer quarterly results, Mycronic reaffirmed its full-year 2025 sales guidance of SEK 7.5 billion, suggesting ongoing confidence in its market outlook and operational plans. With full-year sales guidance confirmed...
OM:HNSA
OM:HNSABiotechs

Hansa Biopharma (OM:HNSA): Five-Year Losses Worsen as Profitability Targets Face Key Risks

Hansa Biopharma (OM:HNSA) posted another year of widening losses, with net losses expanding at an average annual rate of 11.5% over the past five years, and no sign yet of margin improvement. Shares are currently trading at SEK31.2, considerably below the estimated fair value of SEK503.14, while the company’s price-to-sales ratio of 16.2x stands out against a peer average of 27.1x. Despite ongoing unprofitability, investors are focused on the company’s anticipated revenue growth of 48.4% per...
OM:SHB A
OM:SHB ABanks

Is Declining Net Income Shifting the Investment Case for Svenska Handelsbanken (OM:SHB A)?

Svenska Handelsbanken AB recently reported third quarter and nine-month results showing declines in net interest income and net income, with third quarter net income falling to SEK 5.95 billion from SEK 7.21 billion a year earlier. This decrease in financial performance included lower basic and diluted earnings per share for both periods, which could influence investor perception of the company's earnings outlook. We will now explore how this reported drop in earnings and income may impact...
OM:EVO
OM:EVOHospitality

Assessing Evolution’s (OM:EVO) Valuation Following Q3 Earnings Dip

Evolution (OM:EVO) just released its third quarter earnings, showing both revenue and net income dipped compared to the same period last year. These results often spark discussion as investors weigh what this means for future growth. See our latest analysis for Evolution. After Evolution’s earnings miss, momentum in the share price has clearly faded. The 30-day share price return is -17.01%, and there has been a year-to-date decline of -26.89%. Over the past 12 months, total shareholder...
OM:SAVE
OM:SAVECapital Markets

Nordnet (OM:SAVE): Assessing Valuation Following Strong Earnings Growth and Investor Interest

Nordnet (OM:SAVE) just announced its third quarter and nine-month earnings, showing growth in both net income and earnings per share compared to the previous year. This performance will be closely watched by investors. See our latest analysis for Nordnet. Nordnet’s upbeat earnings have helped underpin a steady build in momentum, with investors seeing a 15.6% year-to-date share price return and a standout 28.5% total shareholder return over the past year. The longer view is even more...
OM:BIOG B
OM:BIOG BBiotechs

BioGaia's Surging Quarterly Profits Might Change The Case For Investing In BioGaia (OM:BIOG B)

BioGaia AB (publ) recently announced its earnings results for the third quarter and nine months ended September 30, 2025, reporting SEK 326.64 million in sales for the quarter and SEK 1.10 billion for the nine months period. While third quarter net income more than doubled year-over-year, net income for the nine-month period declined compared to a year ago, reflecting variability in the company's financial performance. We will explore how the strong rebound in quarterly net income could...
OM:THULE
OM:THULELeisure

What Thule Group (OM:THULE)'s Mixed 2025 Earnings Reveal About Its Resilience for Shareholders

Thule Group AB announced its third quarter and nine-month results for 2025, with third quarter sales reaching SEK 2,528 million and net income of SEK 314 million, both higher than the previous year. An interesting detail is that while third quarter profits increased year-on-year, the company's nine-month net income declined to SEK 1,092 million versus SEK 1,159 million a year earlier, highlighting mixed performance over different periods. With Thule reporting higher third quarter profits but...
OM:HEM
OM:HEMInteractive Media and Services

Does Hemnet Group's (OM:HEM) Share Buyback Reflect Strategic Discipline Amid Mixed Quarterly Results?

Hemnet Group AB recently reported third quarter 2025 earnings, with quarterly sales of SEK 366.7 million and net income of SEK 132.4 million, alongside confirming completion of a share buyback tranche totaling 812,500 shares for SEK 223.2 million under its May 2025 program. While quarterly figures showed slight declines versus the prior year, the company's nine-month results reflected year-over-year growth in both revenue and profit, highlighting ongoing momentum in its broader business...
OM:EPRO B
OM:EPRO BMachinery

Electrolux Professional (OM:EPRO B): Assessing Valuation Following Weaker Q3 and Nine-Month 2025 Earnings Results

Electrolux Professional (OM:EPRO B) released its third quarter and nine-month 2025 results, showing lower sales and net income compared to last year. These earnings give investors a fresh look at recent business challenges and trends. See our latest analysis for Electrolux Professional. Following the earnings update, Electrolux Professional’s share price has seen some notable moves. A 1-day gain of just over 1% was quickly offset by a 7-day slide, though an 8% rise over the past month shows...
OM:ERIC B
OM:ERIC BCommunications

Ericsson (OM:ERIC B) Teams Up on 6G Video Standards—Is Its Tech Leadership Set for a New Phase?

Ericsson, Nokia, and Berlin’s Fraunhofer Heinrich Hertz Institute recently partnered to advance next-generation video coding standards for immersive media and mobile experiences in anticipation of the 6G era, marking the first joint demonstration of a new video codec with improved efficiency and scalability. This collaboration not only underscores Europe’s ambitions in defining global technology standards but also signals Ericsson’s positioning at the forefront of innovation in...
OM:TRUE B
OM:TRUE BSoftware

Can Truecaller's (OM:TRUE B) Shift to Subscriptions Offset Weaker Ad Revenue Over Time?

Truecaller AB (publ) recently announced its third quarter 2025 results, reporting sales of SEK 476.62 million and net income of SEK 108.51 million, reflecting higher overall revenue but lower profitability compared to the previous year. A unique highlight was the strong 55% increase in subscription revenues and 39% growth in Truecaller for Business revenue, which helped counter a 1% fall in ad income amid regulatory and economic pressures. We'll examine how the surge in subscription and...
OM:BEIA B
OM:BEIA BMachinery

Beijer Alma (OM:BEIA B): Valuation Perspectives After Q3 Sales Growth and Profit Decline

Beijer Alma (OM:BEIA B) just released its third quarter 2025 earnings, showing a rise in sales compared to last year. However, net income dipped from previous levels. This combination caught the attention of investors and drove a noticeable response in the stock. See our latest analysis for Beijer Alma. The Q3 earnings report set the tone for Beijer Alma’s recent momentum, with shares climbing more than 18% over the past month as investors weighed the growth in sales against a dip in profits...
OM:BONEX
OM:BONEXBiotechs

Why Bonesupport Holding (OM:BONEX) Is Down 6.1% After Strong Q3 Earnings and Sales Momentum

Bonesupport Holding AB (publ) recently announced its third quarter and nine-month earnings results for the period ended September 30, 2025, reporting sales of SEK 294.14 million and net income of SEK 34.51 million for the quarter, both up from the prior year. An interesting aspect of these results is the sustained year-over-year growth in both sales and earnings per share, highlighting persistent operational momentum and improved profitability across the business. We'll explore how continued...